Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report

Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report

<p>Abstract</p> <p>Background</p> <p>Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC) is a rare type of cardiomyopathy. The diagnosis is based on the hourglass appearance on the left ventriculogram and the presence of pressure gradient between apical and...

Full description

Bibliographic Details
Main Authors:	Alioglu Emin, Ercan Ertugrul, Tengiz Istemihan, Turk Ugur O
Format:	Article
Language:	English
Published:	BMC 2006-04-01
Series:	BMC Cardiovascular Disorders
Online Access:	http://www.biomedcentral.com/1471-2261/6/15

Similar Items

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy
by: Tolga Aksu, et al.
Published: (2017-01-01)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
by: Smita Scholtz, et al.
Published: (2023-10-01)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
by: Dirceu Rodrigues Almeida
Published: (2019-04-01)

Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
by: Victor Arévalos, et al.
Published: (2021-05-01)

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety
by: J Veselka
Published: (2007-12-01)

Vector electrocardiographic alterations after percutaneous septal ablation in obstructive hypertrophic cardiomyopathy: possible anatomic causes
by: Pérez Riera Andrés Ricardo, et al.
Published: (2002-01-01)

Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy Under Extracorporeal Membrane Oxygenation Support
by: Takahiro Kobayashi, MD, et al.
Published: (2020-10-01)

Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm
by: N.D. Oryshchyn, et al.
Published: (2016-11-01)

Mid-ventricular obstruction in a patient with hypertrophic cardiomyopathy
by: Kevin Rafael De Paula Morales, et al.
Published: (2022-04-01)

Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Technical review and long-term clinical and echocardiographic outcomes
by: Sílvio Leal, et al.
Published: (2012-05-01)

Contrast Enhanced Echocardiography-Controlled Alcohol Septal Ablation for Hypertrophic Cardiomyopathy with Left Ventricular Outflow Tract Obstruction
by: I. E. Nikolaeva, et al.
Published: (2019-07-01)

Effect of metoprolol in hypertrophic obstructive cardiomyopathy patients after alcohol septal ablation
by: Hana Hnátová, et al.
Published: (2023-12-01)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
by: Felice Gragnano, et al.
Published: (2023-04-01)

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy- Is Myocardial Contrast Echocardiography Mandatory?
by: Sridhar Lakshmana Sastry, et al.
Published: (2022-01-01)

A Case Report of Percutaneous Transluminal Septal Myocardial Ablation in Patients with Hypertrophic Cardiomyopathy
by: Mohammad Hasan Namazi, et al.
Published: (2004-12-01)

Double Balloon Technique for Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) of Hypertrophic Cardiomyopathy
by: Haryadi Adi, et al.
Published: (2013-06-01)

Inter-ventricular Septum Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy
by: Yuejin Wu, MS, Shaobo Duan, MD, Luwen Liu, MS, Shuaiyang Wang, MS, Shuang Xu, MS, Liuwei Hao, BS, Lianzhong Zhang, MD
Published: (2020-12-01)

Surgical septal myectomy versus septal alcohol ablation for hypertrophic obstructive cardiomyopathy: a continuing debate
by: S Meditskou, et al.
Published: (2008-05-01)

Short- and Mid-Term Outcomes of Early Alcohol Septal Ablation Therapy for Patients with Mildly Symptomatic Hypertrophic Obstructive Cardiomyopathy: A Tertiary Center Experience
by: Veysel Oktay, et al.
Published: (2024-03-01)

Twenty years of experience with alcohol septal ablation (ASA) for hypertrophic obstructive cardiomyopathy in Chile
by: Christian Dauverge Maya, et al.
Published: (2022-09-01)

Alcohol septal ablation in obstructive hypertrophic cardiomyopathy is a safe procedure in experienced hands
by: Hubert Seggewiss, et al.
Published: (2020-06-01)

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
by: Alexandru Achim, et al.
Published: (2023-06-01)

The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy
by: B.M. Todurov, et al.
Published: (2020-12-01)

Alcohol Septal Ablation in Patients with Hypertrophic Cardiomyopathy and Obesity
by: K. V. Rudenko, et al.
Published: (2019-05-01)

Predictive value of estimated plasma volume for postoperative hypotension in percutaneous intramyocardial septal radiofrequency ablation treating for hypertrophic obstructive cardiomyopathy
by: Bo Shan, et al.
Published: (2024-03-01)

Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
by: Xifeng Zheng, et al.
Published: (2022-05-01)

Effects of septal myectomy on left atrial and left ventricular function in obstructive hypertrophic cardiomyopathy
by: Kyung Eun Ha, et al.
Published: (2023-10-01)

The Risk of Ventricular Arrhythmias between Alcohol Septal Ablation and Septal Myectomy in Hypertrophic Cardiomyopathy: A Meta-Analysis on Septal Reduction Therapy
by: Wei Tang, et al.
Published: (2022-11-01)

Bail-out alcohol septal ablation in the management of obstructive hypertrophic cardiomyopathy and refractory electrical storm
by: Piero Custodio-Sánchez, et al.
Published: (2020-08-01)

Outcome of patients ≥ 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
by: Denisa Jahnlová, et al.
Published: (2019-04-01)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
by: Qiang Liu, et al.
Published: (2021-11-01)

How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
by: Brandon M. Jones, et al.
Published: (2017-05-01)

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
by: Ibadete Bytyçi, et al.
Published: (2020-09-01)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
by: Watkins, H, et al.
Published: (2005)

Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy
by: Hong-Chang Guo, et al.
Published: (2018-01-01)

Therapeutic benefits of distal ventricular pacing in mid-cavity obstructive hypertrophic cardiomyopathy
by: James W. Malcolmson, et al.
Published: (2022-08-01)

Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia
by: Tengiz Istemihan, et al.
Published: (2009-02-01)

Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathyCentral MessagePerspective
by: Tsuyoshi Yamabe, MD, et al.
Published: (2022-09-01)

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: do mitral valve leaflet length, septal thickness, or sex affect the outcome?
by: Mustafic, Mesud, et al.
Published: (2024)

The need for a pacemaker after alcoholic septal ablation in hypertrophic obstructive cardiomyopathy – Harmful, neutral or beneficial?
by: Katya Reis Santos, et al.
Published: (2024-01-01)